INTRODUCTION
During recent years, clinical and experimental findings have indicated that a major determinant for clinical development following trauma and major surgery is represented by massive alterations of the patients' immune response. 1 Particularly, in experimental models of septic shock, it was found that certain cytokines such as TNF-α, interleukin-1 (IL-1) and adhesion molecules are synthesised in excessive quantities and that these products are able to induce multiple organ failure (MOF) when applied exogenously. 2 Therefore, it has been assumed that the elimination of these inflammatory mediators would be of benefit, e.g. in sepsis, and would prevent development of MOF. However, therapeutic trials in multicenter clinical studies revealed that these concepts did not hold true. 3 In contrast, it turned out that treatment with antibodies against TNF-α had negative effects on the clinical course of some patients. 4 One reason for this may be that TNF-α and IL-1 are essential components for an integer immune response. Hence, neutralisation of TNF-α by antibodies or its elimination by disruption of the gene of the TNF-α p55 receptor in 'knock-out' mice prevented the establishment of an adequate immune response against Mycobacterium tuberculosis or Listeria monocytogenes. 5, 6 More recently, a number of clinical and experimental findings indicate that, in parallel to the pro-inflammatory cytokines, factors are generated which possess antiinflammatory properties. For example, macrophages stimulated in vitro with lipopolysaccharide (LPS) produce TNF-α or IL-1 in parallel with IL-4, IL-10 and PGE 2 or Accidental as well as surgical trauma has been reported to cause reduced endotoxin responsiveness of blood in terms of cytokine production. In this study, the effect of interferon-γ (IFN-γ) on tumour necrosis factor-α (TNF-α)-producing capacity of whole blood after severe trauma and cardiac surgery was investigated. Blood samples of severely injured patients were collected at the first day after trauma and of cardiac surgery patients before, 4 h and 2 days after cardiopulmonary bypass (CPB). The blood samples were incubated with INF-γ (0-100 U/ml) for 20 h and subsequently lipopolysaccharide (LPS)-induced TNF-α production was determined. Compared to healthy donors, LPS-induced TNF-α production was significantly reduced in blood cultures of trauma patients on day 1 after trauma and 4 h after CPB. Pre-incubation with IFN-γ in vitro increased endotoxininduced TNF-α production in volunteers' and all patients' blood specimens in a dose-dependent manner. IFN-γ prompted an elevation of cytokine synthesis in CPB patients' blood which equalled that of volunteers, whereas it caused a lower rise in TNF-α production in blood of multiply injured patients, reaching levels of untreated donors only after incubation with 100 U/ml IFN-γ. These experiments show that hyporesponsiveness of whole blood induced by trauma or cardiac surgery with CPB is not irreversible, but can be counteracted by the immunostimulant IFN-γ. IFN-γ, therefore, could be applied clinically in trauma patients or after cardiac surgery to prevent or to resolve infection complications. PGI 2 , which are endowed with inhibitory properties for the former mediators. [7] [8] [9] This phenomenon seems to be clinically relevant as substantially elevated levels of these mediators have been detected in septic patients as well as after cardiac surgery and severe trauma. [10] [11] [12] [13] [14] [15] Moreover, monocytes from severely injured patients were found to express HLA-DR antigens on their surface to a considerably lower degree than normal individuals. 16 A markedly depressed HLA-DR expression on monocytes has also been found after cardiopulmonary bypass (CPB) in cardiac surgery. 17 In several studies, it was established that severe trauma and major surgery decrease the capacity of patients' blood to generate cytokines in response to endotoxin ex vivo. [18] [19] [20] [21] [22] While the attenuation of the inflammatory response by limiting an overshooting reaction may be of benefit during a traumatising event, it may, on the other hand, prevent the immune system from raising an adequate response needed for the host's defence against infectious complications.
Interferon-γ (IFN-γ) has been reported to increase endotoxin responsiveness of normal monocytes 23 and also to increase HLA-DR expression in situations of pathologically reduced expression; 24 indeed, it has an enhancing effect on the host immune response in general. 25 Therefore, in the present study, the effect of IFN-γ on the endotoxin-induced whole blood TNF-α production in healthy donors, multiply injured patients and individuals undergoing cardiac surgery with CPB was investigated.
MATERIALS AND METHODS

Patients
Multiply injured patients
Patients between 18 and 70 years of age and an Injury Severity Score (ISS) 26 ≥17 points were included in the study. Blood samples were collected on day 1 after trauma at 8 a.m. Six severely injured patients primarily admitted to a university trauma department were studied. The mean ISS 26 was 28 ± 11 points and the mean age was 42.8 ± 15.3 years; 5 male and 1 female patient were included. All patients had fractures of the upper or lower extremity. Additional injuries included thoracic trauma with lung contusion (n = 3), abdominal trauma (n = 2), blunt brain injury (n = 3), spine or pelvis fractures (n = 3), relevant soft tissue damage (n = 2) and maxilla facial fractures (n = 1). None of the patients died.
Cardiac surgery patients
Patients (n = 6) undergoing cardiac surgery for coronary artery-bypass grafting (CABG) or aortic valve replacement (AVR) using CPB were included in the study. The CPB technique was standardised using a roller pump, a flat sheet membrane blood oxygenator and Bretschneider cardioplegia solution for myocardial protection. Blood samples were collected at 8 a.m. before, immediately after CPB and on the 2nd day after cardiac surgery. All patients underwent cardiac surgery applying CPB. Mean ischemic time was 59 ± 15.1 min, mean bypass time was 96.8 ± 31.5 min. Four patients underwent cardiac surgery for aorto-coronary bypass, in 2 patients aortic valves were replaced. One patient died after surgery because of a low output failure syndrome.
Volunteers
Healthy volunteers (n = 9) between 24 and 58 years of age without infectious diseases 4 weeks prior to blood collection served as controls. Blood was withdrawn between 8 and 10 a.m.
Whole blood culture
Heparinised blood was collected in sterile syringes (NH 4heparin-(9 ml)-Monovette, Sarsted, Germany), diluted 1:1 (v/v) in RPMI 1640 medium, supplemented with 64 µg/ml streptomycin and 60 IU/ml penicillin, set up in 48well flat-bottom culture plates in a total volume of 500 µl and incubated at 37°C in a 5% CO 2 and water-saturated atmosphere. Samples were prepared in duplicate. Blood cultures were incubated with 0, 10 and 100 U/ml recombinant human IFN-γ (Genzyme, Munich, Germany) for 20 h and afterwards stimulated with 100 ng/ml LPS (Salmonella friedenau, kindly provided by Dr H. Brade, Forschungsinstitut Borstel, Germany) for 4 h. LPS from S. friedenau activates monocytes in a comparable degree to LPS from Salmonella abortus equi. LPS (100 ng/ml) from S. friedenau results in a maximal TNF-α synthesis in this experimental setting. Supernatants were collected after centrifugation and stored at -20°C until cytokine determination.
TNF-α ELISA
TNF-α was determined using a monoclonal anti-human TNF-α antibody (Genzyme), a polyclonal anti-human TNF-α antiserum raised in rabbits and a horseradishperoxidase (HRP)-conjugated goat-anti-rabbit-IgG serum (Dianova, Hamburg, Germany) as the detection system. For standards, recombinant human TNF-α (Genzyme) was used. ABTS (Sigma, Deisenhofen, Germany) was used as HRP-substrate. The lower detection limit for the TNF-α ELISA was 30 pg/ml.
Statistics
All values are expressed as mean ± standard deviation (SD). For statistical analysis, a paired or unpaired one-tailed Student's t-test was performed (for details see figure captions). A P value ≤0.05 was considered as statistically significant.
RESULTS
Pretreatment of whole blood cultures from healthy donors
with IFN-γ for 20 h resulted in a large rise in LPS-induced TNF-α production in a dose-dependent manner beginning at a concentration of 1 U/ml IFN-γ with further increase up to 7-fold at doses of 1000 U/ml IFN-γ; 1 and 10 U/ml IFN-γ showed similar effects (Fig. 1) . The priming effect of IFN-γ was also seen to a lesser degree after 4 h of preincubation with IFN-γ (data not shown), but was more pronounced after 20 h of pre-incubation; therefore, patients' blood cultures were incubated with IFN-γ for 20 h with 10 and 100 U/ml IFN-γ, respectively.
The LPS-induced TNF-α production of whole blood collected on the first day after trauma was significantly lower than that of blood from healthy donors. Although pre-incubation of blood cultures derived from trauma patients with 10 U/ml IFN-γ could slightly increase LPSinduced TNF-α production, compared to cultures of untreated healthy volunteers it was still significantly reduced. In vitro, 100 U/ml IFN-γ was sufficient to raise TNF-α production to the values of untreated controls. However, IFN-γ treatment of blood drawn from trauma patients always resulted in a lower TNF-α synthesis than that of blood cultures from healthy donors treated with the same dose of IFN-γ (Fig. 2) .
LPS-induced TNF-α secretion of patients' blood samples before surgery was the same as that of healthy volunteers both with and without IFN-γ treatment (Fig. 3 ). Blood collected 4 h after CPB produced significantly less TNF-α after ex vivo LPS stimulation than blood obtained before surgery. Pretreatment with 10 U/ml IFN-γ did not enhance TNF-α production in these samples. In contrast, treatment with 100 U/ml IFN-γ effectively counteracted the suppression, resulting in a 2-fold increase of TNF-α production compared to untreated volunteers' blood or levels before surgery without IFN-γ addition. On the other hand, after treatment of postoperative blood with 100 U/ml IFN-γ, TNF-α production did not reach the levels of healthy donors treated with the same amount of IFN-γ ( Fig.  3) . On the second day after surgery, suppression of TNF-α production almost completely disappeared and only after incubation with 10 U/ml IFN-γ could a significant difference from values before surgery be observed (Fig. 3) .
DISCUSSION
During the last decade, numerous experimental and clinical studies have revealed that diverse insults affect the immune system seriously. Surgical or accidental trauma, hemorrhagic shock and sepsis were shown to be related to strong inflammatory responses such as extensive generalized mediator production. These mediators include TNF-α, IL-1, IL-6, IL-8 and others [27] [28] [29] equipped with a Interferon-γ counteracts reduced endotoxin responsiveness of whole blood 433 Fig. 1 . Priming of LPS-induced TNF-α production of whole blood by IFN-γ. Whole blood drawn from a healthy volunteer was incubated for 20 h at 37°C with different amounts of IFN-γ and then stimulated for 4 h with the amount of LPS indicated. TNF-α is expressed in ng/ml as mean ± SD of a triplicate incubation of a representative experiment. Fig. 2 . LPS-induced TNF-α production of whole blood from trauma patients after pre-incubation with IFN-γ. Whole blood drawn from healthy volunteers (n = 9) and at the first day after trauma (n = 6) was incubated for 20 h at 37°C with 0, 10 and 100 U/ml IFN-γ and then stimulated for 4 h with 100 ng/ml LPS. TNF-α is expressed in ng/ml as mean ± SD. *Indicates statistically different from healthy donors treated with the same amount of IFN-γ at P < 0.05. #Indicates statistically different from untreated healthy donors at P < 0.05. considerable pro-inflammatory potential. From these findings, it was concluded that an early consequence of major trauma would consist in the establishment of a hyperinflammatory state. In parallel to the development of hyperinflammation, a counterbalance seems to evolve consisting of anti-inflammatory cytokines such as IL-4 and IL-10 which have been detected early after trauma in humans. [30] [31] [32] They have been suggested to represent compensatory principles to limit an overshoot of the inflammatory response. If these attenuators are formed in excess, however, they may contribute to immunosuppression, which is a common clinical consequence observed after major surgery and trauma.
In support of this, in experimental hemorrhagic shock, increased amounts of TGF-β have been associated with host immunosuppression. 33 In polytraumatized patients and after cardiac surgery, decreased T-cell functions have been demonstrated by reduced mitogen-dependent proliferative capacity, IL-2 synthesis and IL-2 receptor expression. 34, 35 Furthermore, trauma was found to decrease mitogenevoked immunoglobulin synthesis 36 and, therefore, is suggested to depress B-cell function.
The production of cytokines from whole blood cultures in response to ex vivo stimulation with endotoxin is supposed to represent a measure of the donor's immunocompetence. In the present study the impact of major surgery and accidental trauma on ex vivo cytokine synthesis of patients' blood and the effects of IFN-γ on this capability were analysed. It has been previously described 18, 19, 37 that severe trauma and elective surgery result in reduced endotoxin responsiveness of isolated blood. After cardiac surgery including cardiopulmonary bypass, a decreased ex vivo TNF-α synthesis as well as low HLA-DR expression on monocytes has been observed within the first day. 17, 21, 22, 38 Our finding that the TNF-α producing capacity is reduced after cardiac surgery and in severely injured patients agrees with previously published results. 19, 21, 32, 38 The reduction of TNF-α producing capacity cannot be explained by a reduction of circulating monocytes as the major TNF-α producing cells since the same suppression of TNF-α synthesis is observed when cytokine production is normalized to the amount of monocytes present in the blood culture. 38 Furthermore, it was shown that the anticoagulant heparin does not influence LPS-induced TNF-α production of whole blood. 38 The activating potential of IFN-γ to enhance TNF-α production of monocytes has been well documented. 23, 39 In cases of immunocompromised patients, an immunostimulating therapy with this substance appears to be promising. In trauma patients, this idea has been pursued for almost a decade with varying results concerning outcome and immunological alterations. Hershmann et al. reported that treatment of trauma patients with IFN-γ counteracted the reduction of HLA-DR expression on monocytes. 24 A randomized, multicenter double-blinded trial with a daily treatment of severely injured patients with 100 µg IFN-γ subcutaneously (s.c.) for 10 days 434 Flohé, Börgermann, Lim, Schade Fig. 3 . LPS-induced TNF-α production of whole blood from cardiac surgery patients after pre-incubation with IFN-γ. Whole blood drawn from healthy volunteers (n = 9) and before, 4 h and 2 days after cardiopulmonary bypass (n = 6) was incubated for 20 h at 37°C with 0, 10 and 100 U/ml IFN-γ and then stimulated for 4 h with 100 ng/ml LPS. TNF-α is expressed in ng/ml as mean ± SD. *Indicates statistically different from healthy donors treated with the same amount of IFN-γ at P < 0.05. #Indicates statistically different from untreated healthy donors at P < 0.05. §Indicates statistically different from values before surgery at P < 0.05. resulted in increased HLA-DR expression and a lower rate of infections requiring re-operation or other drainage. 40 In another multicenter trial, IFN-γ (100 µg/day s.c.) was administered to trauma patients for 21 days and resulted in a lower rate of death related to infections. 41 Several clinical studies showed immune-enhancing effects of IFN-γ regarding increased HLA-DR expression on monocytes. [40] [41] [42] In none of the above studies, however, was the individual actual immunological state of the patients (hyper/hypo-inflamed) accounted for to adapt the therapeutic dose of IFN-γ. In contrast, a fixed amount of IFN-γ was applied over the whole study period. Since IFN-γ supposedly has optimal effects during the hyporesponsive phases, this might negatively have influenced the results.
The capacity of IFN-γ to enhance TNF-α synthesis of whole blood has been successfully shown in blood specimens of septic patients. 43 The results of the present study suggest that a similar effect of IFN-γ can be obtained with the blood of trauma patients and after cardiac surgery.
IFN-γ increased the reduced TNF-α producing capacity after severe injury and CPB. However, blood samples of patients 4 h after CPB and after trauma have a lower responsiveness to IFN-γ than healthy donors. Compared to healthy donors' blood, higher doses of IFNγ are necessary to enhance LPS-induced TNF-α production following trauma and CPB patients to the same degree. A similar phenomenon has been reported by Ertel et al., who observed that trauma and sepsis almost completely abolished IFN-γ induced IL-12 production in isolated blood. 44 In agreement with this, LPS-induced IL-12 secretion of blood samples collected from sepsis and trauma patients could be enhanced by in vitro treatment with IFN-γ to a much lesser degree than in blood from healthy donors. 44 When IFN-γ is considered as a therapeutic agent, its known side-effects such as hypersensitization towards bacterial products and its potency to activate macrophages and other cells should be taken into account. In experimental studies, the toxic effects of LPS were found to be potentiated by IFN-γ. 45 However, in a clinical trial, 100 µg IFN-γ s.c. per day was applied to trauma patients and no evidence for an increased inflammatory response was observed. No changes in coagulation disorders or significant differences in circulating TNF-α levels were found after IFN-γ treatment. 46 Pharmacokinetic data showed that application of 100 µg IFN-γ per day results in circulating serum levels of 80-300 U/ml. 47 In agreement with this, our data indicate that TNF-α production in ex vivo stimulated blood of trauma patients reached the levels of blood specimen from healthy individuals after in vitro incubations with similar amounts of IFN-γ. In no case was an over-normal response achieved. In contrast, in blood cultures of patients after CPB, the same dose of IFN-γ resulted in an increase of TNF-α synthesis which was about 100% higher than that of blood from normal donors without IFN-γ. This could possibly indicate that the application of IFN-γ would not be advisable since it could induce a hyperinflammatory response in the patients or at least indicate that IFN-γ treatment in these patients should be performed with lower doses. The data presented here suggest that treatment with IFN-γ might serve as an immunostimulating therapy after trauma and major surgery. Care, however, should be taken to determine the proper occasion for the application in order not to induce hyperinflammation.
